Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study (Q46223922)
Jump to navigation
Jump to search
scientific article published on 30 September 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study |
scientific article published on 30 September 2014 |
Statements
1 reference
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study (English)
1 reference
Julio Rosenstock
1 reference
Robert R Henry
1 reference
Steven Edelman
1 reference
Sunder Mudaliar
1 reference
Alexandros-Georgios Chalamandaris
1 reference
Sreeneeranj Kasichayanula
1 reference
Allyson Bogle
1 reference
Nayyar Iqbal
1 reference
James List
1 reference
Steven C Griffen
1 reference
30 September 2014
1 reference
1 reference
38
1 reference
3
1 reference
412-419
1 reference
Identifiers
1 reference